The article on soluble AXL as novel early biomarker of pancreatic cancer (eBioMedicine 2022), led by Pilar Navarro and Pablo Garcia de Frutos, has been selected as a finalist for the Vanguard Science Award. You can vote here: https://www.lavanguardia.com/ciencia/20230128/8716908/vota-finalistas-premio-vanguardia-ciencia.html
If you want to know more about this work you can check the informative video here: https://youtu.be/PcZVZXZn-Tk
